← Open Payments lookup

MARK FAMADOR: Open Payments

NPI 1184890436 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$406 in 18 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $35 · 2025 $406

Food & beverage: $406
CompanyPaymentsAmount
ABBVIE INC.2$137
Vanda Pharmaceuticals Inc.6$101
Tris Pharma Inc3$52
Supernus Pharmaceuticals, Inc.2$29
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$21
Collegium Pharmaceutical, Inc.1$18
Otsuka America Pharmaceutical, Inc.1$17
Lundbeck LLC1$16
Vertical Pharmaceuticals, LLC1$15

Products named: VRAYLAR, FANAPT, Dyanavel XR, REXULTI, Qelbree, CAPLYTA, Jornay PM, Relexxii.

Industry payments across NJ — which companies pay providers there.